Most biotechs and speculative stocks require an
investor to look ahead farther than a single year.
This company has lots of, (NO, tremendous) potential,
given how dreadful and how widespread are the addictions
it adreses. With more trial-successes and publicity, its
drugs with take off ballistically. The potential is
certainly there for the stocks to quadruple a year after
it hits the jackpot and has its lead drug be the recipient
of wild. well-earned and enthusiastic praise. What are the
odds of this happening? I would day 60%. SO if there is a 60% chance for the stocks to quadruple and a 40% chance for the stock to drop back to $2, that translates to a stock
reaching $32! I am long and quite comfortable with the match!